药学服务在基层医院慢性阻塞性肺疾病延伸处方药中的应用  

Application of pharmaceutical service in chronic obstructive pulmonary extended prescription drugs in primary care hospitals

作　　者：孙君雪 丁冬霞 SUN Junxue;DING Dongxia(Department of Pharmacy,Community Health Service Center of Qingpu District,Shanghai 201715,China;General Practice of Liantang,Community Health Service Center of Qingpu District,Shanghai 201715,China)

机构地区：[1]上海市青浦区练塘镇社区卫生服务中心药剂科,上海201715 [2]上海市青浦区练塘镇社区卫生服务中心全科,上海201715

出　　处：《上海医药》2024年第8期59-62,共4页Shanghai Medical & Pharmaceutical Journal

基　　金：上海市青浦区卫生健康委员会科研项目(QWJ2022-43)。

摘　　要：目的:研究全方位药学服务对社区慢性阻塞性肺疾病(COPD)延伸处方患者的影响。方法:收集练塘镇社区卫生服务中心2021年1月至2022年3月延伸处方中COPD患者80例,年龄50~75周岁,其中男性50例,女性30例。根据用药时是否接受药学干预分为对照组(40例)和干预组(40例),干预组平均年龄(66.275±6.544)岁,平均病程(5.925±1.817)年;对照组平均年龄(67.175±5.913)岁,平均病程(5.875±1.95)年。干预时间6个月。6个月后比较两组患者的用药依从性和对疾病的认知程度,评估两组患者吸入装置的正确使用率,记录不良反应发生情况。结果:干预组患者在干预后对COPD疾病相关知识的认知、用药依从性、药物吸入装置操作正确率均有提高,不良反应发生率降低,差异均有统计学意义(P<0.05)。结论:对社区COPD延伸处方患者给予药学服务干预,在降低药物不良反应发生率的同时还可有效提高患者的用药依从性以及对疾病的认知程度,提升患者吸入装置的正确使用率。Objective:To study the impact of the comprehensive pharmaceutical service on patients with extended prescription of chronic obstructive pulmonary disease(COPD)in the community.Methods:Eighty patients with COPD in extended prescription from January 2021 to March 2022 in Liantang Community Health Service Center were collected and the average age was 50-75 years old,among them,there 50 males and 30 females.They were divided into a control group with 40 cases and an intervention group with 40 cases according to whether they received pharmaceutical intervention at the time of medication administration,and the average age in the intervention group was(66.275±6.544)years,and the average disease course was(5.925±1.817)years;the average age of the control group was(67.175±5.913)years and the average disease course was(5.875±1.95)years.The intervention time was 6 months.After 6 months,the two groups were compared by questionnaires on medication compliance,disease awareness,and the correct use of inhalation devices and recording of adverse reactions were assessed.Results:The patients’knowledge about COPD disease,medication compliance,and correct operation of the drug inhalation device were improved after the intervention,and the incidence of adverse reactions decreased in the intervention group(P<0.05),and the difference was statistically significant(P<0.05).Conclusion:Pharmaceutical service intervention for patients with extended COPD prescriptions in the community reduces the incidence of adverse drug reactions,at the same time effectively improves patients’medication compliance and knowledge of the disease,and increases the correct use of inhalation devices.

关 键 词：慢性阻塞性肺疾病 社区延伸处方 药学服务 吸入装置 依从性 

分 类 号：R563[医药卫生—呼吸系统]